Sunshine Biopharma (SBFM) Interest Coverage Ratio (2012 - 2026)
Sunshine Biopharma (SBFM) posted Interest Coverage Ratio of 7.73 for Q1 2026, down 35.66% on a QoQ basis from 5.7 in Q3 2025, and down 10.17% year-over-year from 8.6 in Q1 2025.
Sunshine Biopharma (SBFM) Interest Coverage Ratio (2012 - 2026) Analysis & Trends
Sunshine Biopharma's Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 7.73 for Q1 2026.
- Quarterly Interest Coverage Ratio fell 10.17% year-over-year to 7.73 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 35.03 (down 13.37% YoY) and the FY2025 annual result came in at 0.74, up 11.62% from the prior year.
- Interest Coverage Ratio was 7.73 for Q1 2026 at Sunshine Biopharma, down from 5.7 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 5.7 in Q3 2025 and bottomed at 858990.0 in Q3 2022.
- A 5-year average of 57355.29 and a median of 12.38 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio plunged 8109137.82% — and 2023, when it surged 100.0%.
- Sunshine Biopharma's Interest Coverage Ratio stood at 880.12 in 2022, then soared by 95.52% to 39.43 in 2023, then plunged by 505.93% to 238.92 in 2024, then surged by 97.62% to 5.7 in 2025, then plunged by 35.66% to 7.73 in 2026.
- Business Quant data shows SBFM's Interest Coverage Ratio at 7.73 in Q1 2026, 5.7 in Q3 2025, and 10.55 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 92.29 Bn | 90.43 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | - |
| 3 | Zoetis | 33.09 Bn | 31.15 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 27.76 Bn | 23.70 Bn | 4.39 Bn | -0.62 |
| 5 | United Therapeutics | 22.94 Bn | 20.79 Bn | 648.10 Mn | 0.18 |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.51 Bn | 18.70 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 18.16 Bn | 16.84 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.84 Bn | 12.41 Bn | 785.00 Mn | 5.11 |
| 10 | Sunshine Biopharma | 696,643.46 | -6.22 Mn | 2.18 Mn | -7.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.73 |
| Sep 30, 2025 | -5.70 |
| Jun 30, 2025 | -10.55 |
| Mar 31, 2025 | -7.01 |
| Dec 31, 2024 | -238.92 |
| Sep 30, 2024 | -10.65 |
| Jun 30, 2024 | -12.38 |
| Mar 31, 2024 | -13.05 |
| Dec 31, 2023 | -39.43 |
| Sep 30, 2023 | -7.08 |
| Jun 30, 2023 | -9.02 |
| Mar 31, 2023 | -17.65 |
| Dec 31, 2022 | -880.12 |
| Sep 30, 2022 | -858,990.00 |
| Mar 31, 2022 | -80.11 |
| Dec 31, 2021 | 1.10 |
| Sep 30, 2021 | -10.59 |
| Jun 30, 2021 | -1.99 |
| Mar 31, 2021 | -25.66 |
| Dec 31, 2020 | -2.04 |